LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

Search

Ultragenyx Pharmaceutical Inc

Closed

SectorHealthcare

24.38 1.41

Overview

Share price change

24h

Current

Min

23.92

Max

24.75

Key metrics

By Trading Economics

Income

-56M

-185M

Sales

-71M

136M

EPS

-1.54

Profit margin

-136.029

Employees

1,371

EBITDA

-56M

-161M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+116.31% upside

Dividends

By Acuity

Next Earnings

4 sie 2026

Market Stats

By TradingEconomics

Market Cap

-313M

2.1B

Previous open

22.97

Previous close

24.38

News Sentiment

By Acuity

50%

50%

156 / 344 Ranking in Healthcare

Ultragenyx Pharmaceutical Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 cze 2026, 23:06 UTC

Social Media
News
ETF Constituents

Invesco QQQ Trust Series I gains after-market, supported by a strong Nasdaq close and SpaceX's debut, maintaining stability since Friday's close.

12 cze 2026, 20:07 UTC

News
Correlated Moves

The USD/DKK is trading higher, reflecting a modest increase since Thursday's close. The US Dollar Index also shows a slight uptick.

12 cze 2026, 20:07 UTC

News

The USD/CZK is trading lower today, reflecting a slight decline since Thursday's close. Recent U.S. producer price data has not significantly impacted the currency pair.

12 cze 2026, 20:07 UTC

News

Baker Hughes oil rig count rises to 433, influencing energy market sentiment. USD/PLN is trading roughly flat during Friday's session.

12 cze 2026, 20:07 UTC

Correlated Moves
Macro Event
News

The U.S. Baker Hughes oil rig count increased to 433, while the Michigan Consumer Sentiment Index rose to a preliminary reading of 48.9. USD/SGD is trading roughly flat.

12 cze 2026, 20:07 UTC

News

The U.S. Baker Hughes oil rig count rose to 433, while USD/THB trades roughly flat since Thursday's close amid routine market fluctuations.

12 cze 2026, 20:07 UTC

News
Macro Event

The USD/SEK exchange rate is lower today, despite a rise in U.S. consumer sentiment reported at 48.9, above expectations.

12 cze 2026, 20:07 UTC

News
Macro Event

USD/HUF trades lower despite a stronger-than-expected Michigan Consumer Sentiment Index, reflecting ongoing inflation concerns and unusual volatility during the session.

12 cze 2026, 20:07 UTC

News

The USD/ZAR is higher, supported by an increase in the Baker Hughes oil rig count, reflecting dynamics in the energy sector impacting currency valuations.

12 cze 2026, 20:02 UTC

News

ASML Holding NV is lower today, even as analysts note strengthening competitive advantages amid diminishing concerns over rival xLight and ongoing demand for its technology.

12 cze 2026, 20:02 UTC

News

Amazon.com Inc. shares are declining amid broadline retail sector weakness, despite recognition of Amazon Web Services as a growth driver.

12 cze 2026, 20:02 UTC

Macro Event
ETF Constituents
News
Macro News
Correlated Moves
Social Media

Financial Select Sector SPDR Fund is higher today, supported by gains in the financial sector and optimism over geopolitical stability following President Trump's Iran negotiations.

12 cze 2026, 20:02 UTC

News
Social Media

Intel's stock rises as Bank of America upgrades to Buy and Google orders three million processing units, reflecting strong market sentiment and bullish options flow.

12 cze 2026, 20:02 UTC

News

Cintas Corp shares are lower as the FTC issues a second request regarding its acquisition of UniFirst, signaling potential delays in the transaction.

12 cze 2026, 20:02 UTC

News

Adobe Inc. shares are trading lower amid analyst downgrades and CFO Dan Durn's upcoming departure. Concerns over a freemium model pressure near-term revenue outlook.

12 cze 2026, 20:01 UTC

News

Speculation about a merger involving Deutsche Telekom has boosted T-Mobile US shares. The stock has shown steady gains since Thursday's close, trading above its 20-day moving average.

12 cze 2026, 19:56 UTC

News
Correlated Moves
Macro Event

Broadcom Inc shares declined as broader market dynamics and economic data weighed on sentiment, despite record Q2 revenue and AI growth.

12 cze 2026, 19:52 UTC

News
Social Media

Workday Inc shares are lower today amid broader declines in the Application Software sector and an insider selling 107,500 shares at $135.54 to $140.37.

12 cze 2026, 19:52 UTC

News
Correlated Moves
Social Media

Wells Fargo raised Qualcomm's price target to $230, contributing to positive sentiment. The stock is trading higher amid optimism for upcoming Investor Day.

12 cze 2026, 19:52 UTC

News

Intuit Inc. shares are lower amid an investigation for securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues for DIY tax filers.

12 cze 2026, 19:51 UTC

News

Amgen Inc. is reassessing data on Tavneos amid FDA scrutiny. Shares are higher as the company challenges the proposal to withdraw the drug's approval.

12 cze 2026, 19:51 UTC

News
ETF Constituents

Health Care Select Sector SPDR Fund declines as key holdings falter, underperforming against gains in Energy, Materials, and Financials sectors.

12 cze 2026, 19:46 UTC

News
Social Media

Alphabet appeals a German court ruling on AI claims and announced a $50 million investment in workforce training, while shares are higher today.

12 cze 2026, 19:42 UTC

News
Social Media

Meta Platforms shares are lower amid reports of widespread service outages affecting Instagram, Facebook, and WhatsApp, with over 62,000 complaints noted.

12 cze 2026, 19:41 UTC

News

Analysts have raised earnings estimates for NetEase, reflecting positive sentiment. Shares are trading higher today, maintaining upward momentum since Thursday's close.

12 cze 2026, 19:41 UTC

News
Correlated Moves
Social Media

Advanced Micro Devices shares rose after Citi upgraded its rating to Buy and raised the price target to $575, citing strong GPU market potential.

12 cze 2026, 19:41 UTC

News
Correlated Moves

Applied Materials Inc is rising amid a broader market rally and Cantor Fitzgerald's price target increase to $650 from $575, reflecting strong investor interest.

12 cze 2026, 19:41 UTC

Social Media
News

WDC shares gain as JPMorgan raises price target to $650.

12 cze 2026, 19:41 UTC

Social Media
News
Correlated Moves
Macro Event

Lam Research Corp shares rise amid a market rally following President Trump's strike cancellation on Iran. Cantor Fitzgerald raised its price target to $425.

12 cze 2026, 19:41 UTC

News

Comcast Corp shares are higher today, driven by gains in the Cable & Satellite sector. The stock remains above Thursday's close despite a slight pullback.

Peer Comparison

Price change

Ultragenyx Pharmaceutical Inc Forecast

Price Target

By TipRanks

116.31% upside

12 Months Forecast

Average 51.87 USD  116.31%

High 96 USD

Low 25 USD

Based on 16 Wall Street analysts offering 12 month price targets forUltragenyx Pharmaceutical Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

14

Buy

2

Hold

0

Sell

Sentiment

By Acuity

156 / 344 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc.; Solid Biosciences Inc.; Regeneron; Abeona; and Daiichi Sankyo Co., Ltd. The company was incorporated in 2010 and is headquartered in Novato, California.
help-icon Live chat